Research priorities in childhood-onset lupus: results of a multidisciplinary prioritization exercise
Authors:
- on behalf of the Childhood Arthritis and Rheumatology Research Alliance and Lupus Foundation of AmericaOAon behalf of the Childhood Arthritis and Rheumatology Research Alliance and Lupus Foundation of America
- Stacy P. ArdoinSAStacy P. Ardoin
- R Paola DalyRDR Paola Daly
- Lyna MerzougLMLyna Merzoug
- Karin TseKTKarin Tse
- Kaveh ArdalanKAKaveh Ardalan
- Lisa ArkinLALisa Arkin
- Andrea KnightAKAndrea Knight
- Tamar RubinsteinTRTamar Rubinstein
- Natasha RuthNRNatasha Ruth
- Scott E. WenderferSWScott E. Wenderfer
- Aimee O. HershAHAimee O. Hersh
Open Access
- 1 July 2019
- journal article
- research article
- Published by Springer Nature in Pediatric Rheumatology
- Vol. 17 (1) , 1-7
Abstract
Childhood-onset systemic erythematosus lupus (cSLE) is characterized by more severe disease, widespread organ involvement and higher mortality compared to adult-onset SLE. However, cSLE is largely underfunded to carry out necessary research to advance the field. Few commonly used SLE medications have been studied in children, and important knowledge gaps exist concerning epidemiology, genetics, pathophysiology and optimal treatments for cSLE. In order to assess highest cSLE research priority areas, the Lupus Foundation of America (LFA) and Childhood Arthritis and Rheumatology Research Alliance (CARRA) administered a cSLE research prioritization survey to pediatric rheumatologists, dermatologists and nephrologists with expertise in lupus. Members of LFA and CARRA’s SLE Committee identified a list of cSLE research domains and developed a 17-item tiered, web-based survey asking respondents to categorize the research domains into high, medium, or low priority areas. For domains identified as high priority, respondents ranked research topics within that category. For example, for the domain of nephritis, respondents ranked importance of: epidemiology, biomarkers, long-term outcomes, quality improvement, etc. The survey was distributed to members of CARRA, Midwestern Pediatric Nephrology Consortium (MWPNC) and Pediatric Dermatology Research Alliance (PeDRA) Connective Tissue Disease group. The overall response rate was 256/752 (34%). The highest prioritized research domains were: nephritis, clinical trials, biomarkers, neuropsychiatric disease and refractory skin disease. Notably, nephritis, clinical trials and biomarkers were ranked in the top five by all groups. Within each research domain, all groups showed agreement in identifying the following as important focus areas: determining best treatments, biomarkers/pathophysiology, drug discovery/novel treatments, understanding long term outcomes, and refining provider reported quality measures. This survey identified the highest cSLE research priorities among leading rheumatology, dermatology and nephrology clinicians and investigators engaged in care of children with lupus. There is a strong need for multidisciplinary collaboration moving forward, which was indicated as highly important among stakeholders involved in the survey. These survey results should be used as a roadmap to guide funding and specific research programs in cSLE to address urgent, unmet needs among this population.Keywords
Funding Information
- Lupus Foundation of America (NA)
This publication has 21 references indexed in Scilit:
- Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritisPediatric Rheumatology, 2018
- Gaps in Mental Health Care for Youth With Rheumatologic Conditions: A Mixed Methods Study of Perspectives From Behavioral Health ProvidersArthritis Care & Research, 2018
- Delays to Care in Pediatric Lupus Patients: Data From the Childhood Arthritis and Rheumatology Research Alliance Legacy RegistryArthritis Care & Research, 2018
- Approach to Membranous Lupus Nephritis: A Survey of Pediatric Nephrologists and Pediatric RheumatologistsThe Journal of Rheumatology, 2017
- Clinical characteristics of children with membranous lupus nephritis: the Childhood Arthritis and Rheumatology Research Alliance Legacy RegistryLupus, 2016
- Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000–2004Arthritis & Rheumatism, 2012
- Lessons from SLE: children are not little adultsNature Reviews Rheumatology, 2012
- Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosusArthritis Care & Research, 2011
- Difference in disease features between childhood‐onset and adult‐onset systemic lupus erythematosusArthritis & Rheumatism, 2008
- Cost of treatment of childhood‐onset systemic lupus erythematosusArthritis Care & Research, 2006